Loading...
Last submissions
-
P. Pautier, A. Floquet, C. Chevreau, N. Penel, C. Guillemet, et al.. A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery. ESMO Open, 2021, 6 (4), pp.100209. ⟨10.1016/j.esmoop.2021.100209⟩. ⟨hal-03623631⟩
-
Antonio Di Meglio, Julie Havas, Arnauld S. Gbenou, Elise Martin, Mayssam El-Mouhebb, et al.. Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy. Journal of Clinical Oncology, 2022, 40 (27), pp.3190--3204. ⟨10.1200/JCO.21.00277⟩. ⟨hal-03855946⟩
-
K. Zhou, M. Renouf, G. Perrocheau, N. Magné, I. Latorzeff, et al.. Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial – PROFIT. Radiotherapy & Oncology, 2022, 173, pp.306-312. ⟨10.1016/j.radonc.2022.06.014⟩. ⟨hal-03748427⟩
-
François Quénet, Dominique Elias, Lise Roca, Diane Goéré, Laurent Ghouti, et al.. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncology, 2021, 22 (2), pp.256-266. ⟨10.1016/s1470-2045(20)30599-4⟩. ⟨hal-03220825⟩
-
-
-
C N Montero-Menei, Laurence Sindji, Emmanuel Garcion, M Mege, D Couez, et al.. Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microglia. Brain Research Journal, 1996, 724 (1), pp.55-66. ⟨10.1016/0006-8993(96)00268-5⟩. ⟨inserm-03436320⟩
-
-
Dorothée Duluc, Murielle Corvaisier, Simon J. Blanchard, Laurent Catala, Philippe Descamps, et al.. Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. International Journal of Cancer, 2009, 125 (2), pp.367 - 373. ⟨10.1002/ijc.24401⟩. ⟨inserm-03377765⟩
-
Gwenaelle Gravis, Jean-Marie Boher, Karim Fizazi, Florence Joly, Franck Priou, et al.. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model. European Urology, 2015, 68 (2), pp.196 - 204. ⟨10.1016/j.eururo.2014.09.022⟩. ⟨inserm-03353959⟩
-
Gwenaelle Gravis, Jean-Marie Boher, Florence Joly, Michel Soulié, Laurence Albiges, et al.. Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial. European Urology, 2016, 70, pp.256 - 262. ⟨10.1016/j.eururo.2015.11.005⟩. ⟨inserm-03343628⟩
-
Pacôme Fosse, Sylvie Girault, Olivier Capitain, Isabelle Valo, Francis Bouchet, et al.. Apport de la TEP-FDG dans le staging initial des cancers du sein localement avancés traités par chimiothérapie néo-adjuvante. Médecine Nucléaire - Imagerie Fonctionnelle et Métabolique, 2012, 36 (2), Non spécifié. ⟨10.1016/j.mednuc.2011.11.011⟩. ⟨hal-03179503⟩
-
-
-
-
V Kepenekian, D Elias, G Passot, E Mery, D Goere, et al.. Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database Multi-Institutional Retrospective Study *, on behalf of the French Network for Rare Peritoneal Malignancies (RENAPE). European Journal of Cancer, 2016, 65, pp.69-79. ⟨10.1016/j.ejca.2016.06.002⟩. ⟨inserm-01368938⟩
-
-
-
-
A. Avril, G. Le Bouëdec, G. Lorimier, J.M. Classe, C. Tunon-De-Lara, et al.. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients Results after 5 years of follow-up. EJSO - European Journal of Surgical Oncology, 2011, ⟨10.1016/j.ejso.2011.04.008⟩. ⟨hal-00710918⟩